Company* |
Company* | Type/Product Area |
Terms/Details (Date) |
| | |||
Acacia Research |
Toppan Printing Corp. (Japan; Pink Sheets:TONPF) |
Multiyear alliance to develop and manufacture microarrays with an electrochemical detection approach |
Toppan will pay CombiMatrix, a unit of Acacia, a $1M up-front fee and additional development and milestone payments (5/9) |
Lynx Therapeutics Inc. (LYNX) and the Institute for Systems Biology |
IBM Corp. (NYSE:IBM) |
Collaboration to study how cells of the immune system respond to infectious diseases |
Lynx's Massively Parallel Signature Sequencing technology will be used to generate gene expression profiles provided by the ISB for the study of inflammatory response to microbial infection; IBM will provide middleware for managing and analyzing the data (6/5) |
MWG Biotech AG (Germany; FSE:NWUG) |
Hitachi Software Engineering (Japan; Pink Sheets:HCHIF) |
Agreement for MWG to license rights to DNA microarrays based on its Oligo Set technology for Japanese sales to Hitachi |
Hitachi will use the sets of complete human and mouse genomes for its range of microarrays (5/6) |
RTS Life Science International* (UK) |
Syrrx Inc.* |
Partnership to develop and market the HTSB Factory, which is integrated instrumentation for high-throughput structural biology |
Financial terms were not disclosed (5/1) |
|
| |||
Notes: | |||
# This chart does not include agreements that involve agricultural product development. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
FSE = Frankfurt Stock Exchange; NYSE = New York Stock Exchange. | |||
